YU5296A - Proteini protiv gojaznosti - Google Patents
Proteini protiv gojaznostiInfo
- Publication number
- YU5296A YU5296A YU5296A YU5296A YU5296A YU 5296 A YU5296 A YU 5296A YU 5296 A YU5296 A YU 5296A YU 5296 A YU5296 A YU 5296A YU 5296 A YU5296 A YU 5296A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- obesity
- patients
- agents
- obesity proteins
- proteins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Dati pronalazak definiše proteine koji se koriste kao agensi protiv gojaznosti, i koji kada se daju pacijentima reguliše njihovo masno tkivo. Saglasno gore navedenome ovakvi agensi omogućavaju pacijentima da prevazidju njihove hendikepe sa preteranom gojaznošću odnosno značajno im smanjuje rizik od dijabetisa tipa II kao i od kardiovaskularnih oboljenja i kancera.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38104895A | 1995-01-31 | 1995-01-31 | |
| US38363895A | 1995-02-06 | 1995-02-06 | |
| US45095P | 1995-06-22 | 1995-06-22 | |
| US216195P | 1995-08-11 | 1995-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU5296A true YU5296A (sh) | 1998-08-14 |
Family
ID=27484996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU5296A YU5296A (sh) | 1995-01-31 | 1996-01-29 | Proteini protiv gojaznosti |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPH10513451A (sh) |
| KR (1) | KR19980701798A (sh) |
| AR (1) | AR002956A1 (sh) |
| AU (1) | AU703316B2 (sh) |
| BR (1) | BR9606999A (sh) |
| CA (1) | CA2211784A1 (sh) |
| CO (1) | CO4480035A1 (sh) |
| CZ (1) | CZ240497A3 (sh) |
| FI (1) | FI973162A (sh) |
| NO (1) | NO973515L (sh) |
| NZ (1) | NZ301589A (sh) |
| PE (1) | PE15197A1 (sh) |
| PL (1) | PL321702A1 (sh) |
| TR (1) | TR199600085A2 (sh) |
| YU (1) | YU5296A (sh) |
-
1996
- 1996-01-29 BR BR9606999A patent/BR9606999A/pt not_active Application Discontinuation
- 1996-01-29 KR KR1019970705195A patent/KR19980701798A/ko not_active Application Discontinuation
- 1996-01-29 NZ NZ301589A patent/NZ301589A/xx unknown
- 1996-01-29 CO CO96003533A patent/CO4480035A1/es unknown
- 1996-01-29 PL PL96321702A patent/PL321702A1/xx unknown
- 1996-01-29 AU AU47052/96A patent/AU703316B2/en not_active Withdrawn - After Issue
- 1996-01-29 YU YU5296A patent/YU5296A/sh unknown
- 1996-01-29 CZ CZ972404A patent/CZ240497A3/cs unknown
- 1996-01-29 CA CA002211784A patent/CA2211784A1/en not_active Abandoned
- 1996-01-29 JP JP8523612A patent/JPH10513451A/ja active Pending
- 1996-01-30 PE PE1996000072A patent/PE15197A1/es not_active Application Discontinuation
- 1996-01-30 AR ARP960101202A patent/AR002956A1/es unknown
- 1996-01-31 TR TR96/00085A patent/TR199600085A2/xx unknown
-
1997
- 1997-07-30 FI FI973162A patent/FI973162A/fi unknown
- 1997-07-30 NO NO973515A patent/NO973515L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ240497A3 (cs) | 1998-01-14 |
| NZ301589A (en) | 1999-02-25 |
| FI973162A (fi) | 1997-09-30 |
| NO973515D0 (no) | 1997-07-30 |
| PL321702A1 (en) | 1997-12-22 |
| NO973515L (no) | 1997-09-29 |
| TR199600085A2 (tr) | 1996-08-21 |
| KR19980701798A (ko) | 1998-06-25 |
| FI973162A0 (fi) | 1997-07-30 |
| BR9606999A (pt) | 1997-10-28 |
| CA2211784A1 (en) | 1996-08-08 |
| AU703316B2 (en) | 1999-03-25 |
| AU4705296A (en) | 1996-08-21 |
| CO4480035A1 (es) | 1997-07-09 |
| JPH10513451A (ja) | 1998-12-22 |
| PE15197A1 (es) | 1997-05-22 |
| AR002956A1 (es) | 1998-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Borle et al. | Management of oral submucous fibrosis: a conservative approach | |
| WO2001096587A3 (en) | Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus | |
| TR199901172T2 (xx) | Yeni ikame edilmi� pirazol t�revleri. | |
| HUP9801826A2 (hu) | HER-2/neu-fehérje intracelluláris doménje, és alkalmazása malignitások megelőzésére és kezelésére | |
| MXPA03006771A (es) | Anticuerpos modificados y metodos de uso. | |
| TR199901174T2 (xx) | Yeni heterosiklilmetil-ikameli pirazol t�revleri. | |
| BR0316050A (pt) | Métodos de tratar, controlar ou prevenir um câncer especìfico e doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com terapia de radiação, terapia hormonal, terapia biológica, ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit | |
| DE60118723D1 (de) | Verwendung von azetogenischen hydrogenotrophischen stämmen zur vorbeugung und behandlung von verdauungskrankheiten | |
| DE60001271D1 (de) | Hydroxymatairesinol in der krebs-prevention | |
| ATE214924T1 (de) | Verwendung von nebivolol als anti-atherogenisches mittel | |
| ATE185149T1 (de) | Immunogene verbindungen mit spezifischem anti- cytokin effekt, methode zur herstellung, pharmazeutische zusammensetzung und reaktionskit der diese enthält | |
| DK1992695T3 (da) | Lectin-transmembran-antigen af type C udtrykt i human prostatacancer og avendelser deraf | |
| DE69931907D1 (de) | Zusammensetzungen aus hagebutten als anti-entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen | |
| DE59811158D1 (de) | Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen | |
| MX9602689A (es) | Usos terapeuticos humanos de los productos de proteina bpi. | |
| ATE450622T1 (de) | Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit | |
| ATE307886T1 (de) | Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung | |
| DE69719754D1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| DE19580890D2 (de) | Lebendvakzine zur Behandlung von Tumorerkrankungen | |
| DE69233143D1 (de) | Anti-hiv-proteine gap31, dap30 und dap32, die sie kodierende dna und ihre therapeutische nutzung | |
| ATE77751T1 (de) | Mittel zur behandlung von knochenkrankheiten. | |
| WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
| FR2746110B1 (fr) | Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants | |
| YU5296A (sh) | Proteini protiv gojaznosti | |
| WO2002055024A3 (en) | Therapeutic modulation of the tumor inflammatory response |